The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

So, the company developed its mRNA Access programme, which provides tools for researchers to design novel vaccines for emerging and neglected infectious diseases. Participating researchers can use ...

The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a deal to jointly develop a ...

Cambridge’s DIOSynVax and Singapore’s ACM Biolabs will be jointly developing a next-generation universal bird flu vaccine with the potential for mucosal delivery to combat the next pandemic. This ...

Malawi on April 17 declared an mpox outbreak after detecting its first three confirmed cases, the World Health Organization ...

CureVac will be responsible for mRNA design, formulation and manufacturing of clinical supply and retains the option to co-promote the vaccine products in Germany. The new deal adds to CureVac ...

ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...

Donald Trump and Elon Musk are making corruption and graft the main business of the US government. They have fired all the ...